Related references
Note: Only part of the references are listed.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Estimation of Equipotent Doses for Anti-Inflammatory Effects of Prednisolone and AZD9567, an Oral Selective Nonsteroidal Glucocorticoid Receptor Modulator
Joachim Almquist et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials
Tove Hegelund Myrback et al.
LANCET RHEUMATOLOGY (2020)
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile
Lena Ripa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal musclele
Jessica A. Chadwick et al.
PHYSIOLOGICAL GENOMICS (2017)
Recovery of steroid induced adrenal insufficiency
Areej K. Younes et al.
TRANSLATIONAL PEDIATRICS (2017)
Mineralocorticoid receptor mediated liposomal delivery system for targeted induction of apoptosis in cancer cells
Priyanka Sharma et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators
Martin Hemmerling et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Decision-making in early clinical drug development
Paul Frewer et al.
PHARMACEUTICAL STATISTICS (2016)
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Belimumab for Systemic Lupus Erythematosus: A Cochrane Systematic Review and MetaAnalysis
Jasvinder A. Singh et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials
Michael M. Ward et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Maps and legends: The quest for dissociated ligands of the glucocorticoid receptor
Andrew R. Clark et al.
PHARMACOLOGY & THERAPEUTICS (2012)
IL-6 Receptor Inhibition Positively Modulates Bone Balance in Rheumatoid Arthritis Patients with an Inadequate Response to Anti-Tumor Necrosis Factor Therapy: Biochemical Marker Analysis of Bone Metabolism in the Tocilizumab RADIATE Study (NCT00106522)
Morten A. Karsdal et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Disease-Drug-Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis
C. Schmitt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Continuous Monitoring of Circadian Glycemic Patterns in Patients Receiving Prednisolone for COPD
Morton G. Burt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
G. Wells et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Pharmacokinetics and drug metabolism in the elderly
Ulrich Klotz
DRUG METABOLISM REVIEWS (2009)
Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line
HP Gaeggeler et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Share Paper
